and leads to an upregulation of a number of proteins, such as erythropoietin, vascular endothelial growth factor (VEGF), endothelin, and the von Willebrand factor. Correspondingly, all these factors have been described as increased in glaucoma patients.
Is Hypoxia Sufficient to Induce Glaucomatous Optic Neuropathy?
A slight but constant reduction of oxygen supplied to an organ like the eye interestingly does not lead to major damage. Most tissues have a certain capacity to adapt to hypoxia. In patients with multiple sclerosis (MS) endothelin plasma concentration, for example, is increased markedly and therefore OBF is decreased. 7 Although a few of these patients get some degree of optic nerve head atrophy, they do not excavate more often than in subjects without MS, a fact that is also true for a number of other diseases, such as polyarthritis. Contrary to the findings in conditions with constant oxygen reduction, unstable, fluctuating OBF is likely to cause glaucomatous damage. 8 Indeed, variation of OBF correlates with progression of glaucomatous damage.
Why is Ocular Blood Flow Unstable in Glaucoma Patients?
OBF is unstable if IOP fluctuates on a high enough or blood pressure on a low enough level to exceed temporarily the autoregulation capacity.
Indeed, IOP fluctuation is related to both an increase in scotomas and an increase in diffuse visual fields damage. 8 OBF, however, is also unstable if autoregulation itself is disturbed.
Reduced autoregulation occurs particularly in patients who suffer from primary vascular dysregulation (PVD) syndrome.
9
What is the Role of Blood Pressure?
Although low blood pressure has been described as a risk factor for glaucomatous damage and its progression for decades, 10 the majority of ophthalmologists still neglected the role of systemic arterial hypotension. 11 Not only have recent studies re-emphasized the important contributory role of low blood pressure, but also they have shown that a fluctuation of blood pressure is even more relevant.
Finally, the best predictor for glaucomatous damage progression is the fluctuation of perfusion pressure.
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Can we Measure Ocular Perfusion Pressure?
Traditionally, ocular perfusion pressure (OPP) is calculated as the difference between systemic blood pressure (measured in the upper arm) and the retinal venous pressure (assumed to be equal to IOP).
Beside the fact that systemic blood pressure is only a relatively weak estimate for retinal arterial pressure, retinal venous pressure is definitively not necessarily equal to IOP. Although this simplification might be acceptable for the majority of healthy people, it is not applicable for glaucomatous patients. 13 Therefore, to quantify OPP, we should measure blood pressure (arterial and venous pressure) directly in the eye. This can be done with the help of an ophthalmodynamometer.
What are the Signs and Symptoms of a Primary Vascular Dysregulation?
Unfortunately, there are no pathognomonic symptoms or signs for the diagnosis of PVD. PVD tends to occur more often in females, in people with low body-mass index, and in subjects with high physical and mental activity. The leading symptoms are cold hands and feet and relatively low blood pressure, particularly at night. 2,10 Interestingly, with a closer look, other signs, such as episodes of silent myocardial ischemia, altered beat-to-beat variation in electrocardiography, alteration in electroencephalography, altered gene expression in the lymphocytes, increased endothelin plasma levels, and others, can be found. When specifically asked for, these patients often indicate that they have a reduced feeling of thirst, altered drug sensitivity, increased smell sensitivity, and altered sleep behavior with a delayed sleep-onset time, in particular when they feel cold. All these symptoms tend to decline with age. 
How is Ocular Blood Flow in Primary Vascular Dysregulation Subjects?
Pulse waves in retinal vessels propagate faster in subjects with PVD than in non-PVD subjects, which indicates that the rigidity of their retinal vessels is higher, despite their anatomically normal appearance. However, in these patients spatial irregularity of retinal vessels is increased, neurovascular coupling is decreased, and autoregulation of OBF is disturbed. 15 The dysfunction of the autoregulation likely depicts the causal relationship between PVD and glaucomatous damage. 
The microvessel (left) with its corresponding clinical picture (right). A: A physiological condition with minimal leakage of fluorescein; B: A glaucomatous optic nerve head with a disturbed blood-brain barrier, as a result of an increase in endothelin-1 and vascular endothelial growth factor (VEGF), which leads to dysfunction of tight junctions and an increase in

What is the Link between Ocular Blood Flow and Splinter Hemorrhages?
Traditionally, splinter hemorrhages were considered to be a consequence of either microinfarction or small vessel rupture.
However, we suggested that these hemorrhages are rather a consequence of a local breakdown of the blood-retinal or blood-brain barrier. 18 
What is the Relationship between Retinal Vein Occlusion and Glaucoma?
Retinal vein occlusions are found more often in glaucoma patients.
Furthermore, both glaucomatous damage and vein occlusion occur more often in subjects with PVD. We suggested that the vein occlusion is not caused primarily by thrombus formation, but rather by a local dysregulation of the vein, either in the lamina cribrosa or at the arteriovenous crossing. 19 This dysregulation again is likely a consequence of a local increase of vasoactive molecules, such as endothelin, either diffusing from the circulating blood or produced in the neural tissue of the retina (Figure 4) . This, in turn, occurs particularly in hypoxic tissue. Therefore, a primary arterial dysfunction may lead to secondary venous dysfunction.
In summary, unstable oxygen supply caused by IOP or blood pressure fluctuations or disturbed autoregulation leads to increased oxidative stress, a main contributor to glaucomatous damage ( Figure 5 ). 20 n
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